| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Who's Got The Monkey Now? Part 2: How To Make Delegation Work For You |
|
Useful Advices - Who's Got The Monkey Now? Part 2: How To Make Delegation Work For You
In my earlier article “Who’s Got The Monkey Now? How To Find Out How Well You Manage Your Time” (http://www.nationallearning.com.au/index_files/HowToMakePeopleFeelBetterAtWork.htm) , I suggested that you may be caring for a cageful of monkeys (other people’s problems) unless you are managing your According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product time effectively, and in particular delegating. For managers, there are two key aspects to successful delegation:
If you are not a manager, or do not have anyone to del ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in gate to, then I suggest the excellent article by Beth Schneider (http://ezinearticles.com/?How-to-Delegate-When-There-is-No-One-to-Delegate-To&id=141500). The key to delegation is to develop within your people, the "initiative to take action" so that they learn to develop their skills and knowled lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e to their full potential. Managers who are successful are always good at delegating. Less successful managers, when asked why they don't delegate more, often reply
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe , If some of these comments sound familiar to you, then the following steps will show you how to:
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ach of your team members. When delegating, it is important to fit the task to the person and to ensure the reason for delegating is appropriate. Firstly, let's look at the pe ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc son. Is it possible to delegate to all your team members? For delegation purposes, team members may be classified as those who:
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi a decision. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically and then report periodically on progress.
Less successful managers keep their team members at the second level, i.e.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ on problems or issues they encounter. As a consequence, their people rarely develop the knoweldge or skills they need to become fully competent.
Successful managers quickly move all their people through to at least level three i.e.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi for a decision, but when doing so recommend appropriate action.
When people are at level three, they are always looking for solutions rather than just stating the problem. Not only do they look for solutions, but when they do bring a problem to you, they bring their recommended solu ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tion. Wouldn’t your life as a manager be so much easier if all your people did this? Successful managers then move individual staff from level three through levels four and five depending on the particular team member’s skill and how quickly they can gain the necessary experience. Many successf dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod l managers take this one step further by involving their team members in the process of "developing initiative". For instance, they explain the five-step “level of initiative” process to them and then ask:
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ies? Using this approach, managers can then be very clear about which aspects of a person’s job the team member can take initiative on, and how much initiative they may take. It is also a great opportunity to talk about training and devel tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen pment strategies to help move people to the next level on particular job responsibilities. In this way, you know exactly who within your team, you can delegate certain tasks to and most importantly, how they will respond. I have developed a Delegation Matrix of the five Levels of Initiative whic t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel I have been using with practising managers for many years. If you would like a free copy, please contact me via www.nationallearning.com.au Let’s now look at the second aspect of delegation – tasks that may be delegated. Tasks suitable for delegation include:
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust cisions. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products add variety and interest to another person’s role. Which tasks could you delegate? Remember these remain part of your job and while you can delegate responsibility for them, you remain accou . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de table for each. One of the questions I am often asked by managers is
If you use the Levels of Initiative protocol by discussing and agreeing each person’s permitted level of initiative, you will note that levels 3,4 & 5 all elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ave built in reporting mechanisms. Make sure you agree how these will operate with your people. Following the guidelines outlined here, will allow you to release some of your monkeys back to where they can be cared for and fed by others – your team! Copyright 2006 The National Learning Institut tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Going Public: How Long Does it Take? Accounts Receivable Management
|